Ocular Therapeutix grants equity awards to eight newly hired employees
OCUL•Ocular Therapeutix granted equity awards to eight newly hired non-executive employees, covering 35,775 shares through stock options and 11,725 shares through restricted stock units.
1. Award terms
Effective Nov. 2, 2026, the awards comprised non-statutory stock options with a 10-year term and restricted stock units. The options vest over four years, with 25% vesting on each recipient’s first employment anniversary and the remainder monthly over the next three years; the restricted stock units vest in equal annual installments over three years. Both are subject to continued service.
